Top Stock Movers Now: Nvidia, Hershey, Supermicro, and More
U.S. equities were down at midday, pulled lower by falling tech stocks.
News
Why Is Cogent Biosciences Stock Trading Higher On Monday?
On Sunday, Cogent Biosciences, Inc. (NASDAQ:COGT) revealed updated clinical results from the Open Label Extension (OLE) portion of the SUMMIT trial of bezuclastinib in patients with non-advanced systemic mastocytosis. Non-advanced systemic mastocytosis is a rare disease that involves mast cell buildup in tissues and organs. Updated clinical data presented at the American Society of Hematology Annual Meeting & Exposition show: 56% mean improvement in Total Symptom Score (TSS) at 24 weeks. 76% of
Nvidia stock falls almost 3% as it faces an antitrust probe in China
Nvidia’s (NVDA) shares fell by almost 3% during mid-day trading on Monday after the Chinese government announced an investigation into the chipmaker. Fellow chipmakers Advanced Micro Devices (AMD) and Marvell (MRVL) also saw their shares fall by 4.4% and 5.2%, respectively.
Omnicom to Purchase Interpublic Group in All-Stock Deal
Omnicom Group (OMC) agreed to acquire Interpublic Group of Cos. (IPG) in an all-stock deal to create
Argentine Oil Output Is Poised to Oust Colombia From South America’s Top Three
(Bloomberg) -- A shale-drilling frenzy in Argentina has put the country on the verge of leapfrogging regional rival Colombia as a top-three crude producer in South America.Most Read from BloombergBrace for a Nationwide Shuffle of Corporate HeadquartersA Chicago Skyscraper Cements the Legacy of a Visionary Postmodern ArchitectCloud Computing Tax Threatens Chicago’s Silicon Valley AmbitionsNYC’s Run-Down Bus Terminal Gets Approval for $10 Billion RevampKansas City Looks Back on its Long, Costly Ri
Eye-Disease Focused Kodiak Sciences Is A Promising 'Turnaround Story For 2025': Analyst Upgrades Stock
Jefferies has upgraded Kodiak Sciences Inc. (NASDAQ:KOD), a biopharmaceutical company focused on retinal (eye) diseases. Kodiak’s lead investigational medicine, tarcocimab, is an anti-VEGF antibody biopolymer conjugate under development for high-prevalence retinal vascular diseases. Tarcocimab is currently being studied in two Phase 3 trials, GLOW2 in diabetic retinopathy and DAYBREAK in patients with wet age-related macular degeneration (wet AMD). Both studies are actively enrolling patients. J
TikTok asks federal appeals court to bar enforcement of potential ban until Supreme Court review
TikTok asked a federal appeals court on Monday to bar the Biden administration from enforcing a law that could lead to a ban on the popular platform until the Supreme Court reviews its challenge to the statute. The legal filing was made after a panel of three judges on the same court sided with the government last week and ruled that the law, which requires TikTok's China-based parent company ByteDance to divest its stakes in the social media company or face a ban, was constitutional. If the law is not overturned, both TikTok and its parent ByteDance, which is also a plaintiff in the case, have claimed that the popular app will shut down by Jan. 19, 2025.